Expert Opinion on Drug Discovery
Volume 19, 2024 - Issue 4
Open access
1,730
Views
0
CrossRef citations to date
0
Altmetric
Drug Discovery Case History
Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy
Violaine Planté-Bordeneuvea Department of Neurology, Henri Mondor University Hospital, AP-HP, Créteil, France;b Mondor Biomedical Research Institute – IMRB, INSERM, U955 Team 10 “Biology of the Neuromuscular System”, Créteil, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-7880-2316View further author information
& https://orcid.org/0000-0002-7880-2316View further author information
Valentine Perraina Department of Neurology, Henri Mondor University Hospital, AP-HP, Créteil, FranceView further author information
Pages 393-402
|
Received 20 Oct 2023, Accepted 15 Jan 2024, Published online: 27 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.